Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin (Q34858025)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin |
scientific article |
Statements
1 reference
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin (English)
1 reference
Louis M Havekes
1 reference
Ulf Landmesser
1 reference
Thomas F Lüscher
1 reference
J Wouter Jukema
1 reference
Ko Willems van Dijk
1 reference
Susan Kühnast
1 reference
Sam J L van der Tuin
1 reference
José W A van der Hoorn
1 reference
Jan B van Klinken
1 reference
Branko Simic
1 reference
Elsbet Pieterman
1 reference
Patrick C N Rensen
1 reference
Hans M G Princen
1 reference
20 August 2014
1 reference
1 reference
36
1 reference
1
1 reference
39-48
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference